Table 2.
Composition | Antimicrobial Activity | Reference |
---|---|---|
F PMMA/DODAB; PMMA/CTAB | E. coli, S. aureus, P. aeruginosa | [28,29] |
F nisin/pediocin/halloysite; nanoclay/nisin/pediocin/starch | L. monocytogenes, C. perfringens | [30] |
F hydroxypropyl methyl cellulose/xyloglucan/gentamicin | E. coli, S. aureus | [36] |
F essential oils, carvacol, thymol in halloysite NT/polyethylene | E. coli | [47] |
F gelatin/ZnO/glycerol | E. coli, L. monocytogenes | [92] |
F latex NPs/quaternized block copolymers |
P. aeruginosa, S. aureus, S. epidermidis, C. parapsilosis |
[115] |
F copolymer of styrene, ethylene, butylene with DNase-like brushes | E. coli, S. aureus | [132] |
F cellulose acetate/quaternized chitosan/anionic soy protein | E. coli, S. aureus | [133] |
C poly hydroxy ethyl methacrylate/antimicrobial peptide | S. aureus, P. aeruginosa | [179] |
C quaternary ammonium salt/poly (N-isopropylacrylamide) | E. coli | [180] |
C PLGA-DPPC-DSPC-CHOL/AMP, doxycyclin | S. aureus, MRSA | [182] |
C Phosphatidylserine coated silver NPs/allylamine plasma polymer film |
S. aureus, P. aeruginosa, S. epidermidis |
[226,227] |
H cationic peptide with β-sheets forming fibers | S. aureus | [35] |
H hydrophobic tripeptide/ciprofloxacin | E. coli, S. aureus, K. pneumoniae | [200] |
H hydroxypropyl methyl cellulose/histatin-5 | C. albicans | [201] |
PMMA/DODAB: polymethylmethacrylate/dioctadecyl dimethyl ammonium bromide; PMMA/CTAB: polymethylmethacrylate/cetyltrimethylammonium bromide; NT: nanotubes; NPs: nanoparticles; PLGA-DPPC-DSPC-CHOL/AMP: Poly lactide-co-glycolide acid-dipalmytoilphosphatidylcholine-distearoylphosphatidylcholine-cholesterol/antimicrobial peptide.